演題抄録

臓器別シンポジウム

開催概要
開催回
第51回・2013年・京都
 

Prospects for Ovarian Cancer

演題番号 : OS19-1

[筆頭演者]
Ronald D. Alvarez:1 

1:Dept of Ob Gyn, Div of Gyn Onc, Univ of Alabama Birmingham, USA

 

Over 225,000 new patients worldwide are diagnosed annually with ovarian cancer, a disease that remains associated with poor overall survival. In this session, we will review new and evolving approaches to the management of patients with advanced ovarian cancer. Topics to be reviewed include the role of neoadjuvant chemotherapy, intraperitoneal and dose dense chemotherapy, anti-angiogenesis agents, and PARP inhibitors. Emerging other molecular targeted therapies and novel clinical trial strategies for investigating these agents will also be reviewed.

前へ戻る